Skip to search formSkip to main contentSkip to account menu

Gestrinone

Known as: 13-Ethyl-17-Hydroxy-18,19-Dinor-17Alpha-Pregna-4,9,11-Trien-20-Yn-3-One, Pregna-4,9,11-Trien-20-Yn-3-One, 13-Ethyl-17-Hydroxy-18,19-Dinor-, (17Alpha)-, 18,19-Dinorpregna-4,9,11-trien-20-yn-3-one, 13-ethyl-17-hydroxy-, (17alpha)- 
A non-estrogenic contraceptive which is a weak progestin with strong anti-progesterone properties. It is effective if used once a week orally or can… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
OBJECTIVE: To compare the efficacy of gestrinone with that of mifepristone for emergency contraception. METHODS: A randomized… 
2005
2005
Tetrahydrogestrinone (18a-homo-pregna-4,9,11-trien-17beta-ol-3-one, THG) is an anabolic androgenic steroid sold to athletes as an… 
Review
1999
Review
1999
  • J. Donnez
  • 1999
  • Corpus ID: 20440864
Review
1994
Review
1994
SummaryMedical treatments of endometriosis rely upon the hormonal dependence of endometriotic implants for further growth and… 
Review
1993
Review
1993
Studies on the natural history of endometriosis have demonstrated that the majority of endometriosis implants tend to progress, a… 
1989
1989
In a study involving over 300 women, gestrinone has been found to induce regression of uterine myomas. Gestrinone was given in… 
1986
1986
To understand the mechanism of biological action of gestrinone (R2323), which has a therapeutic effect against endometriosis, the…